Fig. 2From: The pattern of medication use, and determinants of the prevalence of polypharmacy among patients with a recent history of depressive disorder: results from the pars cohort studyPolypharmacy prevalence among participants with or without a recent history of depressive disorders categorized with top ten most common underlying diseases in the PCS population (from left to right)Back to article page